Biopharmaceutical company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | ACADIA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $700,000 | |
| 2026 | ACADIA PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $600,000 | |
| 2025 | ACADIA PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $590,000 | |
| 2025 | ACADIA PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $750,000 | |
| 2025 | ACADIA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $500,000 | |
| 2025 | ACADIA PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $440,000 | |
| 2024 | ACADIA PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $510,000 | |
| 2024 | ACADIA PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $220,000 | |
| 2024 | ACADIA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $450,000 | |
| 2024 | ACADIA PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $250,000 |
| Client | Filings | Total Income |
|---|---|---|
| ACADIA PHARMACEUTICALS | 26 | — |
| Name | Disclosed Prior Position |
|---|---|
| MICHAEL MATTOON | |
| MARY LACEY REUTHER | |
| SARAH TODD TELLOCK |